- Home
- DHC vs TERN Comparison
DHC vs TERN Comparison
Compare DHC & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHC
- TERN
- Stock Information
- Founded
- DHC 1998
- TERN 2017
- Country
- DHC United States
- TERN United States
- Employees
- DHC N/A
- TERN N/A
- Industry
- DHC Real Estate Investment Trusts
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- DHC Real Estate
- TERN Health Care
- Exchange
- DHC Nasdaq
- TERN Nasdaq
- Market Cap
- DHC 856.4M
- TERN 710.6M
- IPO Year
- DHC N/A
- TERN 2021
- Fundamental
- Price
- DHC $4.10
- TERN $8.02
- Analyst Decision
- DHC Strong Buy
- TERN Buy
- Analyst Count
- DHC 1
- TERN 7
- Target Price
- DHC $5.50
- TERN $13.99
- AVG Volume (30 Days)
- DHC 555.0K
- TERN 1.7M
- Earning Date
- DHC 11-03-2025
- TERN 11-12-2025
- Dividend Yield
- DHC 0.96%
- TERN N/A
- EPS Growth
- DHC N/A
- TERN N/A
- EPS
- DHC N/A
- TERN N/A
- Revenue
- DHC $1,522,835,000.00
- TERN N/A
- Revenue This Year
- DHC $4.05
- TERN N/A
- Revenue Next Year
- DHC $3.08
- TERN N/A
- P/E Ratio
- DHC N/A
- TERN N/A
- Revenue Growth
- DHC 4.29
- TERN N/A
- 52 Week Low
- DHC $2.00
- TERN $1.87
- 52 Week High
- DHC $4.65
- TERN $9.03
- Technical
- Relative Strength Index (RSI)
- DHC 44.54
- TERN 50.59
- Support Level
- DHC $4.11
- TERN $7.12
- Resistance Level
- DHC $4.36
- TERN $8.87
- Average True Range (ATR)
- DHC 0.13
- TERN 0.65
- MACD
- DHC -0.01
- TERN -0.07
- Stochastic Oscillator
- DHC 31.56
- TERN 50.57
About DHC Diversified Healthcare Trust of Beneficial Interest
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs. Majority of revenue is from SHOP segment.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.